The CSF levels of two of the tryptic peptides of SNAP-25 (Ac-2-16 and 17-31) were significantly higher in patients with Alzheimer’s disease compared with controls in two of the three examined clinical cohorts. Here, SNAP25 is linked to early-onset autosomal dominant Alzheimer disease.